Inactive Instrument

ImmunoVaccine Inc. Share Price Toronto S.E.

Equities

End-of-day quote Toronto S.E. Other stock markets
- ^CAD	-

2023	Transcript : IMV Inc., Q4 2022 Earnings Call, Mar 16, 2023
2022	Transcript : IMV Inc., Q3 2022 Earnings Call, Nov 11, 2022

Transcript : IMV Inc., Q4 2022 Earnings Call, Mar 16, 2023	16/23/16
Transcript : IMV Inc., Q3 2022 Earnings Call, Nov 11, 2022	11/22/11
Transcript : IMV Inc., Q2 2022 Earnings Call, Aug 11, 2022	11/22/11
Transcript : IMV Inc. - Shareholder/Analyst Call	29/22/29

IMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property Assets	04/23/04	AQ
IMV Inc. : to Present at Two Upcoming Investor Conferences	14/19/14	BU
Imv : New Phase 2 Clinical Trial Results Continue to Demonstrate Potential Clinical Benefit of IMV’s DPX-Survivac in Combination with Merck’s Keytruda in Patients with DLBCL	12/19/12	BU

12/19/12

Managers	Title	Age	Since
Andrew Hall CEO	Chief Executive Officer	-	10/20/10
Brittany Davison DFI	Director of Finance/CFO	-	-
Jennifer Schmitke COO	Chief Operating Officer	-	-

Members of the board	Title	Age	Since
Michael P. Bailey CHM	Chairman	58	01/20/01
Kyle Kuvalanka BRD	Director/Board Member	56	01/21/01
Markus Warmuth BRD	Director/Board Member	53	06/18/06

IMV Inc. is a Canada-based company. The Company has no business operations.

Sector

	1st Jan change	Capi.
MODERNA, INC.	+18.97%	4.53TCr
LONZA GROUP AG	+41.98%	4.04TCr
IQVIA HOLDINGS INC.	-10.06%	3.79TCr
ALNYLAM PHARMACEUTICALS, INC.	+31.15%	3.18TCr
CELLTRION, INC.	-7.79%	2.77TCr
ICON PUBLIC LIMITED COMPANY	+13.32%	2.65TCr
UNITED THERAPEUTICS CORPORATION	+43.05%	1.4TCr
MEDPACE HOLDINGS, INC.	+31.28%	1.24TCr
BIO-TECHNE CORPORATION	-7.41%	1.13TCr